Laborate Pharmaceuticals India Limited

laborate.com

Indian based Global Pharmaceuticals company with one of the fastest growing rate in the Industry! Laborate was started in 1985 with the mission to help this world specially the poor with better healthcare facility. Our team is working hard in over 35 countries around the globe to serve the mission with excellence. Laborate is certified y World Health Organisation (WHO) and Joint accreditation System of Australia and New Zealand. We take pride on our self for providing excellent healthcare service at affordable price!

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Views and Analysis

INNOVENT AND IASO BIO PRESENT UPDATED DATA OF BCMA CAR-T CELL THERAPY (EQUECABTAGENE AUTOLEUCEL) AT EHA 2022

Innovent Biologics | June 13, 2022

news image

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, and IASO Biotherapeutics a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products, today jointly announced that the updated data from phase 1/2 study of Equecabtagene Autoleucel (Inno...

Read More

Pharmacy Market

WUXI BIOLOGICS LAUNCHES FIRST COMMERCIAL DRUG PRODUCT FACILITY FOR PRE-FILLED SYRINGES

WuXi Biologics | June 06, 2022

news image

WuXi Biologics a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi Biologics. The DP5 facility features an advanced isolator filling line for continuous and steady filling services, which offers multiple volume delivery options for pre-filled syringes including 1 mL Long, 1 mL, 2.25 mL and 3 mL. The m...

Read More

Business Insights

ABCELLERA AND EMPIRICO EXPAND STRATEGIC MULTI-TARGET ANTIBODY DISCOVERY COLLABORATION

AbCellera | May 04, 2022

news image

AbCellera and Empirico Inc. announced today that they have expanded their strategic multi-target discovery collaboration, which leverages Empirico’s Precision Insights PlatformTM to discover genetically validated drug targets and AbCellera’s technology to identify lead candidate antibodies against those targets. Following the rapid progress of their first collaborative program, which identified a lead candidate against an undisclosed G protein-coupled receptor target in less than 12 ...

Read More

Pharma Tech

DOUGLAS PHARMACEUTICALS FORMS LEAD PROGRAM R-107 CLINICAL ADVISORY BOARD

Douglas Pharmaceuticals | January 27, 2023

news image

A clinical advisory board has been established to support Douglas Pharmaceuticals' lead program R-107, an oral extended-release dose of racemic ketamine being developed as an adjunctive or stand-alone therapy for treatment-resistant depression. Douglas Pharmaceuticals is a New Zealand-based pharmaceutical company specializing in the development of specialty generic and repurposed medications (TRD). Peter Surman, Chief Scientific Officer expressed, "We are ver...

Read More
news image

Views and Analysis

INNOVENT AND IASO BIO PRESENT UPDATED DATA OF BCMA CAR-T CELL THERAPY (EQUECABTAGENE AUTOLEUCEL) AT EHA 2022

Innovent Biologics | June 13, 2022

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, and IASO Biotherapeutics a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products, today jointly announced that the updated data from phase 1/2 study of Equecabtagene Autoleucel (Inno...

Read More
news image

Pharmacy Market

WUXI BIOLOGICS LAUNCHES FIRST COMMERCIAL DRUG PRODUCT FACILITY FOR PRE-FILLED SYRINGES

WuXi Biologics | June 06, 2022

WuXi Biologics a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi Biologics. The DP5 facility features an advanced isolator filling line for continuous and steady filling services, which offers multiple volume delivery options for pre-filled syringes including 1 mL Long, 1 mL, 2.25 mL and 3 mL. The m...

Read More
news image

Business Insights

ABCELLERA AND EMPIRICO EXPAND STRATEGIC MULTI-TARGET ANTIBODY DISCOVERY COLLABORATION

AbCellera | May 04, 2022

AbCellera and Empirico Inc. announced today that they have expanded their strategic multi-target discovery collaboration, which leverages Empirico’s Precision Insights PlatformTM to discover genetically validated drug targets and AbCellera’s technology to identify lead candidate antibodies against those targets. Following the rapid progress of their first collaborative program, which identified a lead candidate against an undisclosed G protein-coupled receptor target in less than 12 ...

Read More
news image

Pharma Tech

DOUGLAS PHARMACEUTICALS FORMS LEAD PROGRAM R-107 CLINICAL ADVISORY BOARD

Douglas Pharmaceuticals | January 27, 2023

A clinical advisory board has been established to support Douglas Pharmaceuticals' lead program R-107, an oral extended-release dose of racemic ketamine being developed as an adjunctive or stand-alone therapy for treatment-resistant depression. Douglas Pharmaceuticals is a New Zealand-based pharmaceutical company specializing in the development of specialty generic and repurposed medications (TRD). Peter Surman, Chief Scientific Officer expressed, "We are ver...

Read More

Resources

resource image

Research, VIEWS AND ANALYSIS

Pharma R&D Annual Review 2023

Whitepaper

resource image

Business Insights, PHARMACY MARKET

SINOPED liquid capsule filling machine

Video

resource image

Research, Business Insights

Demystifying content marketing for the pharma industry

Whitepaper

resource image

Research, VIEWS AND ANALYSIS

Pharma R&D Annual Review 2023

Whitepaper

resource image

Business Insights, PHARMACY MARKET

SINOPED liquid capsule filling machine

Video

resource image

Research, Business Insights

Demystifying content marketing for the pharma industry

Whitepaper

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us